Clinical trial
Efficacy and Tolerability of Beclomethasone Dipropionate 100 µg + Formoterol 6…
NCT00413387 · Chiesi Farmaceutici S.p.A., Industry · Completed
Key facts
| NCT number | NCT00413387 |
|---|---|
| Title | Efficacy and Tolerability of Beclomethasone Dipropionate 100 µg + Formoterol 6 µg pMDI Via HFA-134a Vs. Budesonide 160 µg + Formoterol 4,5 µg Dry Powder Via Turbuhaler®. (Symbicort®) |
| Official title | Double Blind, Double Dummy, Multinational, Multicentre, Parallel-Group Design Clinical Trial of the Efficacy and Tolerability of CHF 1535 (Beclomethasone Dipropionate 100 µg + Formoterol 6 µg) pMDI Via HFA-134a Vs. Budesonide 160 µg + Formoterol 4,5 µg Dry Powder Via Turbuhaler® (Symbicort®) in the… |
| Lead sponsor | Chiesi Farmaceutici S.p.A., Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Bronchial Asthma |
| Intervention type | Drug |
| Interventions | beclomethasone dipropionate plus formoterol fumarate combination, budesonide plus formoterol combination |
| Enrollment | 219 |
| Start date | Sep 1, 2004 |
| Primary completion | Aug 1, 2005 |
| Completion | Oct 1, 2005 |
| First posted | Dec 19, 2006 |
| Last update posted | Aug 3, 2020 |
| Countries | Austria, Poland, Ukraine |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: